Inhibitors of chemical carcinogens as probes for molecular targets: DNA as decisive receptor for metabolite from N-hydroxy-N-2-fluorenylacetamide.
D000081:Acetamides / Q000494:pharmacology; D000083:Acetanilides / Q000494:pharmacology; D000818:Animals; D002247:Carbon Isotopes; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D002701:Chloramphenicol / Q000494:pharmacology; D004247:DNA / Q000378:metabolism*; D004336:Drug Antagonism; D005449:Fluorenes / Q000378:metabolism*; D006147:Guanine / Q000494:pharmacology; D006877:Hydroxamic Acids / Q000378:metabolism; D007211:Indoles / Q000494:pharmacology; D007288:Inosine / Q000494:pharmacology; D008099:Liver / Q000166:cytology / Q000378:metabolism*; D008297:Male; D008715:Methionine / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism; D012335:RNA, Ribosomal / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013268:Stimulation, Chemical; D013347:Subcellular Fractions / Q000187:drug effects; D014052:Toluidines / Q000494:pharmacology; D014364:Tryptophan / Q000494:pharmacology; D014443:Tyrosine / Q000494:pharmacology
D000081:Acetamides; D000083:Acetanilides; D002247:Carbon Isotopes; D005449:Fluorenes; D006877:Hydroxamic Acids; D007211:Indoles; D011506:Proteins; D012335:RNA, Ribosomal; D014052:Toluidines; D014443:Tyrosine; D007288:Inosine; D006147:Guanine; D002701:Chloramphenicol; D014364:Tryptophan; D004247:DNA; D008715:Methionine